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ABSTRAK 
 
 
Pengenalan 
Hidrosefalus didefinisikan sebagai jumlah cecair cerebrospinal (CSF) yang tidak 
sesuai dalam ruang intrakranial pada tekanan yang tidak sesuai. Keputusan untuk 
merawat hidrosefalus adalah berdasarkan puncanya. Perubahan hemodinamik CSF 
disebabkan oleh keadaan seperti pendarahan subaraknoid dan ventrikal, meningitis 
dan teanan luar dari ketumbuhan otak mempunyai kebarangkalian untuk reda selepas 
rawatan; maka, lencongan sementara CSF perlu dipertimbangkan. 
Ventriculosubgaleal shunt (VSGS) boleh digunakan untuk lencongan sementara CSF 
kerana ia adalah satu kaedah yang mudah dan cepat, dan dapat mengurangkan 
tekanan CSF tanpa menyebabkan pengurangan elektrolit dan nutrisi. 
 
Objektif 
Untuk mengenalpasti sama ada VSGS boleh mencapai lencongan sementara CSF 
bagi pesakit dewasa berbanding EVD, untuk mengenalpasti sama ada lencongan 
sementara ini dapat mengelakkan lencongan kekal, dan untuk mencari insiden 
komplikasi intrakranial seperti ventriculitis dan skala Rankin (diubahsuai), sepanjang 
masa kedua-dua jenis cara lencongan CSF itu diperlukan.  
 
Kaedah 
  xiv 
Ini adalah satu kajian rekod pesakit. Data yang diperolehi daripada nota-nota kes 50 
pesakit yang menghidapi hidrosefalus akut: 26 mengalami pendarahan intraventrikal, 
10 mengalami pendarahan aneurisma, 8 pesakit trauma, dan 6 pesakit yang mendapat 
jangkitan. Kesemua pesakit-pesakit ini telah menjalani pembedahan lencongan 
sementara CSF di Hospital Queen Elizabeth II antara tahun 2013 dan 2015. Pesakit-
pesakit ini mendapat rawatan susulan dari tarikh rawatan sehingga resolusi 
hidrosefalus. Maklumat penting seperti keperluan lencongan CSF kekal dan 
komplikasi pembedahan direkod dalam borang yang disediakan. 
 
Keputusan 
Sejumlah 21 (42%) pesakit menjalani rawatan EVD dan 29 (58%) pesakit menjalani 
rawatan VSGS. Sebanyak 37 (74%) pesakit tidak memerlukan shunt kekal; 24 
(64.8%) daripada mereka adalah daripada kumpulan VSGS (p=0.097). EVD 
mempunyai jumlah komplikasi intrakranial yang signifikan (44.1%) berbanding 
dengan VSGS (23.5%), dengan p < 0.026. 
 
Kesimpulan 
Meskipun setiap modaliti rawatan mempunyai komplikasi tersendiri, kajian ini 
menunjukkan bahawa VSGS adalah setara dengan EVD sebagai langkah lencongan 
sementara CSF. Disebabkan tiada signifikan secara statistik antara kedua-dua 
kaedah, VSGS adalah satu pilihan yang baik kerana mempunyai nilai klinikal, 
dengan potensi untuk kesinambungan rawatan pesakit di pusat-pusat yang tiada 
servis neurosurgikal, berbanding dengan EVD. VSGS didapati mempunyai kurang 
komplikasi intrakranial berbanding dengan EVD, dan penemuan ini adalah signifikan 
secara statistik.  
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Title 
Comparison between Ventriculosubgaleal Shunt and Extraventricular Drainage to 
treat Acute Hydrocephalus in Adults at Hospital Queen Elizabeth between 2013 and 
2015: A Retrospective Study 
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Introduction 
Hydrocephalus is defined as an inappropriate amount of cerebrospinal fluid (CSF) 
within the intracranial space at an inappropriate pressure. The decision to treat 
hydrocephalus is based on its various aetiologies. Transient alterations of CSF 
hemodynamics due to conditions such as subarachnoid and intraventricular 
haemorrhages, meningitis, and external compression from tumours may resolve after 
treatment; thus, temporary CSF diversion can be considered. A ventriculosubgaleal 
shunt (VSGS) can been used for temporary CSF diversion because it is a simple and 
rapid method, and establishes CSF decompression without causing electrolyte and 
nutritional losses. 
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Objectives 
To study the efficacy of VSGS as a means of temporary CSF diversion, compared to 
EVD in adult hydrocephalus patients; to evaluate the outcome in terms of avoiding a 
permanent shunt, and to look for incidences of intracranial complications such as 
ventriculitis and modified Rankin scale, between the year 2013 and 2015. 
 
Methods 
This is a retrospective review of records. The data has been acquired from case notes 
of 50 patients with acute hydrocephalus: 26 secondary to intraventricular 
haemorrhage, ten from aneurysm rupture, eight post-trauma and six from infection. 
All these patients had undergone cerebrospinal fluid diversion in Hospital Queen 
Elizabeth II between 2013 and 2015. The patients were followed-up from the date of 
treatment until the resolution of hydrocephalus, where parameters such as shunt 
dependency and complications were documented in a pro forma. 
 
Results 
A total of 21 (42%) patients underwent EVD insertion and 29 (58%) underwent 
VSGS. Thirty-seven (74%) patients did not require a permanent shunt; 24 (64.8%) of 
them were from the VSGS group (p=0.097). EVD had more intracranial 
complications (44.1%) compared with VSGS (23.5%), with a statistically significant 
p value of 0.026. 
 
Conclusion  
While each treatment modality has its own complications, this study shows that 
VSGS is comparable with EVD as a temporary CSF diversion measure. As there are 
  xvii 
no statistical differences between these two modalities, VSGS is a viable option that 
has clinical value, with the possibility of continuation of treatment for such patients 
in non-neurosurgical centres, as opposed to patients with EVDs. Also, VSGS has 
statistically significant less intracranial complications compared with EVD.  
 
Keywords 
Hydrocephalus, extraventricular drainage, EVD, ventriculosubgaleal shunt, VSGS, 
cerebrospinal fluid diversion, CSF, permanent shunt, ventriculoperitoneal shunt.  
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Introduction: Hydrocephalus is defined as an inappropriate amount of cerebrospinal 
fluid (CSF) within the intracranial space at an inappropriate pressure. The decision to 
treat hydrocephalus is based on its various aetiologies. Transient alterations of CSF 
hemodynamics due to conditions such as subarachnoid and intraventricular 
haemorrhages, meningitis, and external compression from tumours may resolve after 
treatment; thus, temporary CSF diversion can be considered. A ventriculosubgaleal 
shunt (VSGS) can been used for temporary CSF diversion because it is a simple and 
rapid method, and establishes CSF decompression without causing electrolyte and 
nutritional losses. 
 
Objectives: To study the efficacy of VSGS as a means of temporary CSF diversion, 
compared to EVD in adult hydrocephalus patients; to evaluate the outcome in terms 
of avoiding a permanent shunt, and to look for incidences of intracranial 
complications such as ventriculitis and modified Rankin scale, between the year 2013 
and 2015. 
 
Patients and Methods: This is a retrospective review of records. The data has been 
acquired from case notes of 50 patients with acute hydrocephalus: 26 secondary to 
intraventricular haemorrhage, ten from aneurysm rupture, eight post-trauma and six 
from infection. All these patients had undergone cerebrospinal fluid diversion in 
Hospital Queen Elizabeth II between 2013 and 2015. The patients were followed-up 
from the date of treatment until the resolution of hydrocephalus, where parameters 
such as shunt dependency and complications were documented in a pro forma. 
 
Results: A total of 21 (42%) patients underwent EVD insertion and 29 (58%) 
underwent VSGS. Thirty-seven (74%) patients did not require a permanent shunt; 24 
(64.8%) of them were from the VSGS group (p=0.097). EVD had more intracranial 
complications (44.1%) compared with VSGS (23.5%), with a statistically significant 
p value of 0.026. 
 
Conclusion: While each treatment modality has its own complications, this study 
shows that VSGS is comparable with EVD as a temporary CSF diversion measure. As 
there are no statistical differences between these two modalities, VSGS is a viable 
option that has clinical value, with the possibility of continuation of treatment for 
such patients in non-neurosurgical centres, as opposed to patients with EVDs. Also, 
VSGS has statistically significant less intracranial complications compared with 
EVD. 
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 1 
INTRODUCTION 
 
 
Hydrocephalus is a term derived from Greek: hydro meaning water and kefale 
meaning skull. It is defined as the state of excessive intracranial accumulation of 
cerebrospinal fluid (CSF) in the ventricular system of the brain (Richard et al., 
2004). It is frequently, but not always, characterised by ventriculomegaly or signs of 
raised intracranial pressure (ICP). 
 
Hydrocephalus is the result of excessive production, circulation or absorption of 
CSF. It can be classified into communicating or non-communicating based on its 
underlying aetiology. Both forms can be congenital or acquired, and the management 
can be challenging and complex. Because the aetiologies and clinical presentations 
of hydrocephalus are so various, many treatment options must be considered, ranging 
from temporary to permanent surgical options.  
 
Temporary methods in the management of acute hydrocephalus are commonly 
required. Several procedures and devices had been proposed, such as external 
ventricular drainage (EVD), repeated lumbar drainage, repeated lumbar puncture, 
Ommaya reservoir insertion for frequent tapping or ventricular subgaleal shunt 
(VSGS). All those methods are routinely used in clinical practice, but which of these 
procedures is chosen depends on many factors, including medical, patient and 
environmental factors. 
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The primary treatment goal for hydrocephalus must be normalization of impaired 
CSF flow, aimed at achieving a state of arrested hydrocephalus (Oi, 2005). All those 
temporary CSF diversion methods have their intrinsic drawbacks, and there is no 
consensus over the treatment of hydrocephalus.  
 
Even after temporary methods in the management of hydrocephalus, some patients 
will not need any further treatment, while many others will require a permanent 
surgical solution (Peretta et al., 2007). For those patients who need a definitive 
treatment, there are 2 options: either placement of permanent CSF diversion device 
or neuro-endoscopic procedures.   
 
CSF diversion with a permanent ventriculoperitoneal shunt (VPS) is commonly 
related to multiple complications, with frequency of up to 50% in the first 2 years of 
operation (Drake et al., 1998). Complications related to permanent shunt including 
obstruction, malposition, disconnection, and infection may bring about the 
requirement of at least 1 further operation, adding potential morbidity and mortality. 
To minimize the problems connected with VPS at time of implantation, the CSF has 
to be clear, with low protein levels and no clots or debris present in the ventricles. 
Until the VPS can be inserted, temporary CSF diversion is indicated (Nagy et al., 
2013). 
 
Neuro-endoscopic procedures can be the choice of treatment but requires 
improvement of endoscopic technology and skills, especially in developing countries 
(Stagno et al., 2013). Endoscopic third ventriculostomy (ETV) is one such neuro-
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endoscopic procedure, but it is indicated for obstructive hydrocephalus. 
Communicating hydrocephalus has traditionally been a contraindication for ETV. 
Recent evidence shows that ETV may be successful in some normal pressure 
hydrocephalus patients, or may be indicated if there is a lack of desired effects after 
shunting, or with infectious complications associated with VPS (Yadav et al., 2012).  
 
Alternatively, EVD and VSGS have been used in our centre for temporary CSF 
diversion because both are simple and rapid methods, establishing CSF 
decompression. VSGS provides physiologic drainage of CSF and protects the brain 
by dampening the pressure wave. Some amount of CSF and its contents are probably 
reabsorbed in the subgaleal space, thereby reducing protein and electrolytes loss 
(Köksal and Öktem, 2010).  
 
In the attempt to avoid permanent shunt and the need for revision, which adds 
potential morbidity and mortality, multiple methods have been suggested, including 
endoscopic treatment for obstructive hydrocephalus, treating the underlying causes 
such as tumour resection, and haematoma evacuation. Koksal and Oktem performed 
VSGS for 25 patients and 3 of them with grade 1 and 2 germinal matrix haemorrhage 
(12%) did not require permanent shunts (Köksal and Öktem, 2010). Kariyattil et al 
performed VSGS for 21 meningitic hydrocephalus patients and one of them did well 
without any further shunt (Kariyattil et al., 2008).  For IVH due to ICB and SAH, 
50% of patients who treated only with EVD required permanent shunt (Basaldella et 
al., 2012).  
  
This is a retrospective observation of acute hydrocephalus adult patients due to 
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different aetiologies, given two different treatments (VSGS and EVD), as their 
dependency of permanent shunt was yet to be determined at the time of presentation 
in Hospital Queen Elizabeth between 2013 and 2015. We determined the outcome in 
terms of avoiding permanent shunt, number of procedure required, and complications 
due to each treatment modality.  
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CHAPTER 1: HYDROCEPHALUS 
 
 
1.01: PATHOPHYSIOLOGY 
 
Cerebrospinal fluid (CSF) flows in the ventricular system in the brain. Ventricular 
anatomy includes two lateral C-shaped ventricles separated by a midline septum 
pellucidum, where each has a frontal foramen of Monroe that connects into the third 
ventricle; the third ventricle connects posteriorly with the fourth ventricle through 
the Aqueduct of Sylvius; the fourth ventricle sits between the brainstem anteriorly 
and the cerebellum posteriorly and drains CSF through the central foramen of 
Magendie and two lateral foramens of Luschka to be spread to around the brain and 
spinal cord.  
 
Physiologically, CSF is a clear and colourless fluid produced by choroid plexus 
within the ventricles (80%), interstitial space, ventricular ependymal and nerve root 
sleeves dura mater; reabsorbed by arachnoid villi of the dural venous sinuses, 
choroid plexus and cervical lymphatics back into the venous system driven by 
hydrostatic gradient.  
 
Daily CSF production and volumes: Newborns: 25mls produced per day, with a total 
volume of 5mls at any one time; adults: 0.3-0.35ml/min (450-750 ml/day) produced, 
with a total volume of 150ml at any one time. The 150mls of CSF volume is reached 
by the age of 5 years old. Production is pressure independent (Kershenovich, 2014).  
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The pathophysiology of hydrocephalus can be further divided into 4 forms: disorders 
of CSF circulation, absorption, production or dynamics.   
1. Disorders of CSF circulation 
This form of hydrocephalus results from obstruction of the pathways of CSF 
circulation. This can occur at the ventricles or any other point within the CSF 
space up to the arachnoid villi. Tumour, haemorrhages, congenital 
malformations and infections can cause obstruction at any point in the 
pathways. 
 
2. Disorders of CSF absorption  
This form of hydrocephalus is the result of interfering with CSF absorption at 
the arachnoid granulations such as cerebral venous sinus thrombosis, 
meningitis, subarachnoid haemorrhage or superior vena cava syndrome. 
 
3. Disorders of CSF production 
This is the rarest form of hydrocephalus. Choroid plexus papillomas and 
choroid plexus carcinomas can secrete CSF in excess to its absorption 
capacity. 
 
4. Unclassified or not well understood disorders of CSF dynamics 
Some form of hydrocephalus cannot be classified clearly. This group of 
hydrocephalus include normal pressure hydrocephalus. Besides enlargement 
of the ventricles, disturbed CSF dynamics can also lead to other diseases like 
idiopathic intracranial hypertension, syringomyelia and Tarlov’s cyst.   
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1.02: NATURAL HISTORY AND CLINICAL PRESENTATION 
 
The various types of hydrocephalus will present differently in different age groups.  
Acute hydrocephalus in adults is related to the elevation of intracranial pressure 
(ICP), manifested by a clinical triad of headache, nausea or vomiting, and 
papilledema. Headache tends to be poorly localized or bifrontal. It gets worse when 
recumbent due to maximal ICP when flat. It can be temporarily relieved with 
analgesics and upright posture. As the ICP rises, headaches become more likely to 
awaken the patient from sleep, and more severe and resistant to analgesics. Nausea 
and vomiting, like headache, tend to accompany raised ICP. Papilloedema is a more 
common finding in the hydrocephalus of adults. Abducens or 6th cranial nerve palsy 
can occur as a false localizing sign in hydrocephalus. Episodic visual obscuration or 
sometimes described as “greying” accompanies dangerous pressure waves and 
suggests the need for emergent ventricular drainage (Rengachary and Ellenbogen, 
2005). 
 
However, in infants, irritability and poor head control can be the only and early signs 
of hydrocephalus. As the frontanelles and sutures are still open, infants can present 
with bulging frontanelles, dilated scalp veins and increasing head circumference. 
When the third ventricle dilates, the patient can present with Parinaud syndrome 
(upward palsy with a normal vertical Doll response) or the setting sun sign (Parinaud 
syndrome with lid retraction and increased tonic downgaze). When advanced, 
hydrocephalus presents with coma and haemodynamic instability, which can lead to 
death.   
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1.03: EPIDEMIOLOGY AND DEMOGRAPHICS 
 
The incidence of paediatric hydrocephalus as an isolated congenital disorder is 
approximately 1/1000 live births. The prevalence and incidence of hydrocephalus in 
developed nations are estimated as 0.9 to 1.2 per 1000 live births and 0.2 to 0.6 per 
1000 live births respectively. No reliable estimate is available in most of the 
developing nations, but its incidence is likely to be higher due to inadequate 
antenatal diagnosis, high rates of untreated or poorly treated perinatal infections, and 
nutritional deficiencies (Stagno et al., 2013).  
 
Adult hydrocephalus has no documented incidence or prevalence in Malaysia. In 
Hospital Kuala Lumpur, a general hospital with neurosurgical services located in the 
capital city of Malaysia, performed 400 cases of CSF diversion in adult, aged 14 to 
73 years old between December 2006 to December 2008. Those hydrocephalus were 
secondary to subarachnoid haemorrhage (SAH), spontaneous or traumatic 
intraventricular haemorrhage (IVH), intraparenchymal bleed or tumour associated 
hydrocephalus (Omar and Haspani, 2010).  
 
 
1.04: DIAGNOSTIC EVALUATION 
 
Hydrocephalus can be evaluated by computed tomography (CT) or magnetic 
resonance imaging (MRI) of the brain to visualize the entire ventricular system. 
There is a range of normal ventricular size changes with age, rendering absolute 
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measurements of the ventricular dimensions of little use. Some radiological features 
are strongly suggestive of hydrocephalus when occurring in combination (Tandon 
and Ramamurthi, 2011).  
Hydrocephalus is suggested when the size of both temporal horns are 2mm or more, 
when the Sylvian fissure, inter-hemispheric fissures and cerebral sulci are not visible, 
or when the ratio FH/ID is more than 0.5, where the FH is the largest width of the 
frontal horns and the ID is the inner diameter from inner-table to inner-table at the 
level in the axial cut of CT brain.  
 
Other features suggestive of hydrocephalus are:  
1. Ballooning of third ventricle and/or frontal horns of lateral ventricle, with the 
appearance of “Mickey mouse” ventricles.  
2. Periventricular low density on CT, or periventricular high intensity signal on 
T2-weighted MRI secondary to transependymal absorption of CSF, 
especially at the tips of the frontal, occipital and temporal horns.  
3. Evans ratio of the frontal horns’ largest width to maximal biparietal diameter 
measured in the same CT axial slice more than 0.3 (Figure 1-03). 
4. Sagittal MRI may show thinning and/or upward bowing of the corpus 
callosum.    
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Figure 1-01: Axial view of plain CT brain showing diffuse subarachnoid 
haemorrhage with hydrocephalus.  
 
 
Figure 1-02: Axial view of plain CT brain showing left thalamic haemorrhage with 
intraventricular extension with hydrocephalus. (Ishii et al., 2008)  
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Figure 1-03: Axial view of T1WI of MRI brain showing hydrocephalus. A= largest 
width of frontal horns; B= maximal biparietal diameter (Ishii et al., 2008). 
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1.05: CLASSIFICATION 
 
Hydrocephalus can be classified based on onset, symptoms, pathology and other 
specific types as described by Oi and Shizuo (Table 1-01). Their clinical and 
pathophysiology features may even change over time following treatment. 
 
Table 1-01: Classification of hydrocephalus (Oi, 2005) 
Entity involved Parameters Subtypes 
Patient Onset  Congenital/acquired 
Fetal/neonatal/infantile/child/adult/geriatric 
Acute/subacute/chronic 
Causes Primary/secondary/idiopathic 
Underlying lesions Dysgenetic/posthaemorrhagic/post-SAH/post-
IVH/postmeningitic/post-traumatic/brain 
tumour/spinal cord tumour/brain 
abscess/arachnoid cyst/cysticercosis, etc. 
Symptomatology  Macrocephalic/normocephalic/microcephalic 
Occult/symptomatic/overt 
Coma/stupor/dementia 
Hydrocephalus/parkinsonism complex. Etc. 
Hydrocephalus Pathophysiology Communicating/non-communicating 
- CSF circulation Non-obstructive/obstructive 
External/internal/interstitial 
Isolated compartments: UH/isolated fourth 
ventricle/isolated rhombencephalic/Iisolated 
central canal dilatation/double-compartment 
hydrocephalus/disproportionately large fourth 
venricle, etc. 
- CSF dynamics High/normal 
- Chronology Slowly progressive/progressive/long-
standing/arrested 
Treatment  Post-shunt Shunt-dependent/shunt-independent 
Slit-like ventricle/slit ventricle syndrome, etc.  
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Classifying hydrocephalus based on communicating or non-communicating is useful 
in terms of management and in deciding the safeness to perform lumbar puncture. 
Communicating hydrocephalus is characterized by pan-ventricular dilatation and 
occurs as a result of obstruction to the flow of CSF in the subarachnoid space, distal 
to the foraminal of Luschka and Magendie. Therefore, there is communication 
between the ventricles and the subarachnoid space. This condition is commonly 
caused by infection, haemorrhage, or is idiopathic. Lumbar puncture is generally 
safe.  
 
Non-communicating hydrocephalus is characterized by a pattern of ventricle 
dilatation that reflects the site of obstruction. Non-communicating hydrocephalus is 
also known as obstructive hydrocephalus, as the term non-communicating denotes 
obstruction within the ventricular system or at the level of the outlets of the fourth 
ventricle. Common aetiologies of obstructive hydrocephalus are as shown in Figure 
1-04. Lumbar puncture may be dangerous for patients with non-communicating 
hydrocephalus. 
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Figure 1-04: Common sites and causes of cerebrospinal fluid obstruction 
(Rengachary and Ellenbogen, 2005). 
 
 
1.06: TREATMENT 
 
Medical therapy is usually a temporary measure. Hydrocephalus secondary to 
transient conditions, such as cerebral venous sinus thrombosis, meningitis, neonatal 
intraventricular haemorrhage, medical therapy can be effective.  
 
Acetazolamide is a carbonic anhydrase inhibitor; it is given 25mg/kg/day in 3 
divided doses orally, increased by 25mg/kg/day until 100mg/kg/day is reached. Side 
effects of acetazolamide are electrolyte imbalance, lethargy, tachypnea, diarrhea and 
paresthesias, such as tingling sensation in the fingertips. 
 
Frusemide is a diuretic agent, start simultaneously with acetazolamide, given 1mg 
/kg/day in 3 divided doses, orally. Electrolytes and fluid balance must be monitored 
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carefully with serial electrolyte while giving these medications. Maintain medical 
therapy for a trial of 6 months, and then taper the dosage over 2-4 weeks.  
 
However, medical therapy should only be considered as an adjunct to definitive 
treatment or as a temporizing measure. Weekly computed tomography of the brain or 
close observation for evidences of acute hydrocephalus is essential to detect 
progressive ventriculomegaly, which needs surgical decompression of the ventricle.  
 
Surgical intervention is the definite treatment for hydrocephalus if it progresses and 
is associated with increased ICP. It can be achieved by diverting the CSF flow from 
the ventricular system to where it is readily absorbed or by draining out continuously 
or intermittently. The decision for definitive or temporary CSF shunting depends on 
the disease’s pathology; transient alteration in CSF hydrodynamics such as infection, 
haemorrhage, or tumour might resolve after treatment, and a temporary shunt can be 
considered.  Endoscopic procedure can be considered for patients with obstructive 
hydrocephalus. Correction of the causative factor may solve the hydrocephalus, such 
as removal of tumour or haematoma.  
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CHAPTER 2: LITERATURE REVIEW 
 
 
2.01: CLASSIFICATION OF HYDROCEPHALUS 
 
Hydrocephalus is the cause of major morbidity for children and adults across the 
globe (Stagno et al., 2013). As mentioned in the previous chapter, hydrocephalus can 
be classified into communicating and non-communicating, which can affect the 
decision of the treatment based on the different aetiologies. 
 
Non-communicating or obstructive hydrocephalus can be congenital or acquired, 
causing internal or external obstruction at any point of the CSF pathway within the 
ventricle. Congenital aetiologies include Chiari 1 malformation, aqueductal stenosis, 
Dandy Walker malformation, and arachnoid cyst. Acquired aetiologies include 
masses and post-operative hydrocephalus.   
 
Communicating or non-obstructive hydrocephalus is CSF blocked at the arachnoid 
granulation. Congenital causes are Chiari II malformation, intrauterine infection, 
germinal matrix haemorrhage and syndromic craniosynostosis. Acquired 
communicating hydrocephalus can be secondary to infection, post haemorrhage due 
to trauma or spontaneous intracranial bleed, post operation, or dural venous 
thrombosis.  
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Hydrocephalic syndromes such as acute, chronic and arrested hydrocephalus may 
affect the urgency of CSF diversion and hence the timing for surgery intervention 
(Kershenovich, 2014).   
 
Acute hydrocephalus can occur within hours from the onset of obstruction, 
characterized by a rapid and progressive rise in intracranial pressure if the cranial 
sutures are closed. These patients become progressively obtunded and exhibit signs 
of central trans-tentorial herniation with increasing intracranial pressure, and rapidly 
followed by death unless urgent treatment is given. 
 
Chronic hydrocephalus occurs when the ventricular obstruction is incomplete; 
compensatory changes like expansion of the skull if the cranial sutures are open, 
contraction of the cerebral vascular volume or brain atrophy can prevent a rapid 
death. 
 
Arrested hydrocephalus is chronic hydrocephalus with ventriculomegaly or 
progressively smaller ventricles where there is neither increased intracranial pressure 
(ICP) nor new symptoms. However, establishing the diagnosis of arrested 
hydrocephalus is difficult and needs a longer period of observation for signs of raised 
ICP or neurological function.   
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2.02: SURGICAL TREATMENT OF HYDROCEPHALUS 
 
CSF shunts are the most common treatment for hydrocephalus available worldwide. 
However, shunts are frequently related to high complications and need re-
intervention. There is no consensus over the treatment of hydrocephalus. Because the 
aetiology and clinical presentation of hydrocephalus are so various, many treatments 
must be considered, ranging from transient to permanent surgical options.  
 
There are a few types of shunts being proposed. Definitive CSF shunts include 
ventriculoperitoneal shunts (VPS), ventriculopleural shunts, ventriculoatrial shunts 
and lumboperitoneal shunts. Other not commonly used CSF shunts are ventricular-
gallbladder shunts and ventricular-ureter shunts (Drake and Sainte-Rose, 1995).  
 
Temporary CSF shunts include extraventricular drainage (EVD), external lumbar 
drainage, ventriculosubgaleal shunts (VSGS), ventricular catheter to a subgaleal 
reservoir, or repeated lumbar puncture. These temporary CSF shunts procedures are 
considered where the alteration of hydrodynamic of the CSF is transient, such as 
haemorrhage, infection or tumour. However, repeated tapping of CSF only provides 
intermittent relief from raised intracranial pressure (Rahman et al., 1995). External 
lumbar drainage or EVD provides continuous drainage but is difficult to maintain for 
long periods due to the risk of secondary infection. It also makes the patients 
confined to bed for long periods, and monitoring by a neurosurgery team is required 
(Kariyattil et al., 2008).  
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Endoscopic third ventriculostomy (ETV) may be considered for obstructive 
hydrocephalus with patent subarachnoid spaces and adequate CSF absorption. 
Success rate exceeding 75% for hydrocephalus patients with acquired aqueductal 
stenosis or tumour obstructing third or fourth ventricle. However, for patients 
presented with haemorrhage or infection have generally demonstrated poor response 
to ventriculostomy, less than 50% success rate (Chakraborty et al., 2012).  
 
 
2.03: DECISION TO TREAT ACUTE HYDROCEPHALUS 
 
Temporary or permanent CSF shunt procedures proposed are all routinely used in 
clinical practice, but choosing which one to adopt depends on many factors, 
including medical, patient and environmental factors. No one particular shunt 
procedure is suitable for all patients. Since a permanent shunt insertion is a lifetime 
commitment to an imperfect device, all attempts should be made to avoid a 
permanent shunt. The restoration of a normal CSF circulation will always be better 
than any artificial drainage (Drake and Sainte-Rose, 1995).  
 
Hydrocephalus due to brain tumour in the posterior fossa will be cured by tumour 
removal in a large number of patients, up to 80% (Epstein and Murali, 1978). There 
is a general consensus that a preoperative shunt should be avoided since it may 
induce shunt dependency in patients who are no longer hydrocephalic after tumour 
surgery and do not need a shunt. 
 
For haemorrhagic hydrocephalus following germinal matrix haemorrhage, head 
injury, rupture of vascular anomalies or aneurysm, the consequences of CSF 
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hydrodynamics are similar. At the acute stage, clots generated by the bleeding create 
mechanical obstacles to CSF flow in the narrowest parts of its pathways: in the 
aqueduct of Sylvius, cisternae, subarachnoid spaces or arachnoid villi. CSF viscosity 
following bleeding is insufficient to induce hydrocephalus. At the chronic stage, 
leptomeningeal fibrosis may develop in some cases, leading to a permanent increased 
resistance to CSF flow. Hence not all of these patients will become permanently 
hydrocephalus. Treatment of the acute phase of the ventricular enlargement using a 
temporary method of drainage may save a significant number of patients from a 
permanent shunt (Gurtner et al., 1992).  
 
Hydrocephalus caused by meningitis is communicating hydrocephalus, reflecting 
failure of CSF circulation in the basal cisterns and failure of resorption through the 
arachnoid granulations (Wang et al., 2005). In the retrospective study, 21% (28/136) 
of meningitis patients had been detected to have hydrocephalus. Among these 28 
patients, 7 patients underwent EVD during the acute phase of bacterial meningitis; 4 
of them survived with normal outcomes. It showed that therapeutic regimens for 
meningitis hydrocephalus should be designed to eradicate bacterial pathogens 
primarily, subsequently treating neurological complication such as hydrocephalus 
with CSF diversion.  
 
Post-traumatic hydrocephalus (PTH) is quite variable, ranging from 0.7-29% based 
on worldwide literature (Sarkari et al., 2010). PTH commonly occurs within the first 
year post-trauma. In many cases, initial brain damage leads to cerebral atrophy with 
secondary ventriculomegaly, also known as hydrocephalus ex-vacuo, which can give 
rise to a false impression of PTH. Kishore et al found that only 13.7% of patients 
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with ventriculomegaly had PTH (Kishore et al., 1978). SAH has been cited as an 
important pathology leading to hydrocephalus due to obliteration of subarachnoid 
spaces with fibrous thickening of lepto-meninges, particularly in the sulci of 
convexity and base of the brain (Foroglou and Zander, 1971). Decompressive 
craniectomy has been found to be associated with development of PTH by altering 
CSF pressure dynamics, mechanical blockage around convexities or inflammation of 
arachnoid granulations by post-surgical debris (Waziri et al., 2007). PTH is a 
treatable complication of head injury with a favourable outcome and hence needs to 
be managed with surgical CSF diversion (Sarkari et al., 2010).  
 
Hydrocephalus due to tumour, PTH, post-haemorrhagic and post-infectious causes 
needs CSF diversion. The previous literature recommends a permanent VPS as a 
definitive treatment; however, the complications of shunt infections and blockage or 
malfunction can seriously affect the life of already handicapped patients. All 
attempts should ne made to avoid a permanent VPS if the alteration of CSF 
haemodynamic is transient, and due to all those pathologies and might resolve after 
treatment. For such cases, temporary methods must be considered. (Drake and 
Sainte-Rose, 1995).  If the hydrocephalus is shunt-dependent, the CSF has to be clear 
with low protein level (less than 2g/L), and no clots or debris should be present in the 
ventricles to minimize the problems related to the VPS at the time of implantation 
(Nagy et al., 2013). Temporary CSF diversion methods have to be considered until 
the permanent VPS can be inserted.  
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2.04: EXTRAVENTRICULAR DRAINAGE 
 
EVD is a temporary method of ventricle decompression for acute hydrocephalus. It 
can drain out CSF by a combination of gravity and intracranial pressure via a 
ventricular tube connected outside the brain (Figure 2-01). The drainage rate depends 
on the height at which the EVD system is placed relative to the patient’s anatomy, 
using the tragus as a referent point, which corresponds to the Foramen of Monroe.  
 
EVD is used to relieve ICP by draining out CSF, monitor the intracranial pressure 
and for intraventricular delivery of antimicrobial or chemotherapy agents (Quinones-
Hinojosa, 2012). EVD allows drainage of CSF continuously at a specific level; 
however, it requires sending CSF samples for surveillance and culture, and hence 
requires neurosurgical care in the hospital. 
 
An EVD is inserted into the lateral ventricle at any point along the mid-pupilary line 
with a trajectory that is perpendicular to the skull. Frontal location is the most 
commonly used site, via the right Kocher’s point because the right frontal lobe is part 
of the non-dominant hemisphere in most patients. Intra-operatively, patients lie 
supine with the head of bed slightly elevated around 20-30 degrees and the neck in a 
neutral position. The entry point on the scalp is measured and marked, and the 
shaved area is scrubbed and draped. Local anaesthesia is injected subcutaneously at 
the planned incision and at the drain exit sites. Incision is made down to the bone at 
the marked site, large enough to permit passage of the drill for making the burr hole 
on the skull. The dura is then punctured for the passage of the EVD catheter. The 
catheter with its stylet is inserted perpendicular to the brain surface to a depth no 
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greater than 5cm below the inner table of the skull, the stylet then is withdrawn to 
ensure CSF flow. The distal end of the catheter is tunnelled under the galea to an exit 
site at least 5cm distant from the entry site. The catheter is secured to the scalp using 
a 2-0 silk suture. The incision closed in layers. The distal end of the catheter is 
connected to an adapter, and then to either a drainage system or a pressure transducer 
for ICP monitoring.  
 
After EVD placement, it will be connected outside the brain to facilitate the drainage 
of CSF continuously. Once the CSF is clear from blood for post haemorrhagic 
hydrocephalus or infection for meningitis, the EVD is slowly raised and then 
clamped. The patient is considered successfully weaned off the EVD with the goal of 
removing it after a successful clamp trial. However, if a patient develops clinical 
changes (headache, altered mental status, nausea or vomiting), an ICP elevation 
above 20mmHg, leakage from the EVD site or worsening radiographic 
hydrocephalus after raising or clamping the EVD, then the weaning is considered a 
failure. EVD must be lowered or unclamped to drain the CSF continuously. There 
may be further attempts to wean the EVD.  If the patient fails one or more clamp 
trials, a VPS is placed, as supported in a recent study by Lewis and Taylor, which 
showed a significant association between wean failure due to clinical changes and 
requirement of VPS placement (Lewis and Taylor Kimberly, 2014).  
 
EVD carries a 1.1% risk of intra-cerebral haemorrhage with intraventricular 
extension, from which 0.5% requires surgical evacuation. The incidence of 
malposition of EVD requiring operative reposition is 3%, while the incidence of 
malfunction or obstruction is 6%. For aneurysmal subarachnoid haemorrhage, 
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excessive CSF drainage can increase the transmural pressure across aneurysmal 
dome and increase the risk of re-bleeding in unsecured ruptured aneurysm (Connolly, 
2002).  
 
EVD systems expose the intraventricular environment to the exterior. The frequency 
of EVD-related infection at Hospital Kuala Lumpur was as high as 32.2% (Omar and 
Haspani, 2010). EVD-associated CSF infection can occur with the infection 
identified at a mean of 5.5 ± 0.7 days post insertion. The risk is higher with multiple 
elective EVD revisions. 48% of EVD-associated infection is by Acinetobacter spp. 
And is associated with potential morbidity and mortality. An EVD must be closely 
monitored in the neurosurgical unit as long as the draining is needed for 
improvement of CSF or resolution of hydrocephalus (Connolly, 2002) (Kariyattil et 
al., 2008). 
 
